Kazia Therapeutics (KZIA) has announced a significant adjustment regarding its American Depositary Shares (ADS) aimed at improving its position on the Nasdaq exchange. The company plans to alter the ADS ratio, with the change set to become effective on October 28, 2024. This strategic move comes in response to Nasdaq’s requirements for a minimum bid...
Premium Membership Required
You must be a Premium member to access this content.
Already a member? Log in here